Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Market Cap	97.84M
Revenue (ttm)	30.49M
Net Income (ttm)	-37.36M
Shares Out	77.96M
EPS (ttm)	-0.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	103,261
Average Volume	73,108
Open	1.320
Previous Close	1.330
Day's Range	1.150 - 1.320
52-Week Range	0.720 - 2.960
Beta	0.97
RSI	48.58
Earnings Date	Apr 25, 2025

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography r...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 30
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: BIOWKS

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.